Protease chymotrypsin mediates the endothelial expression of P- and E-selectin, but not ICAM and VCAM, induced by placental trophoblasts from pre-eclamptic pregnancies

Placenta

Volumn 24, Issue 8-9, 2003, Pages 851-861

  Wang, Y ^a   Zhang, Y ^a   Lewis, D F ^a   Gu, Y ^a   Li, H ^a   Granger, D N ^a   Alexander, J S ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; CHYMOTRYPSIN; CHYMOTRYPSIN INHIBITOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; PADGEM PROTEIN; PROTEINASE; THROMBIN INHIBITOR; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ACTIVATION; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; HUMAN; HUMAN CELL; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RIBONUCLEASE PROTECTION ASSAY; TROPHOBLAST; UPREGULATION;

EID: 0141838038     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4004(03)00132-2     Document Type: Article

References (24)

1. Barden A, Graham D, Beilin LJ, Ritchie J, Baker R, Walters BN & Michael CA (1997) Neutrophil CD 11B expression and neutrophil activation in pre-eclampsia. Clinical Science, 92, 37-44.
2. Bussolino F, Benedetto C, Massobrio M & Camussi G (1980) Maternal vascular prostacyclin activity in pre-eclampsia. Lancet, 2(8196), 702.
3. Cockell AP, Learmont JG, Smarason AK, Redman CWG, Sargent IL, & Poston L (1997) Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. Br J Obstet Gynaecol, 104, 235-240.
4. Downing I, Shepherd GL & Lewis PJ (1980) Reduced prostacyclin production in pre-eclampsia. Lancet, 2(8208-9), 1374.
5. Dye JF, Jablenska R, Donnelly JL, Lawrence L, Leach L, Clark P & Firth JA (2001) Phenotype of the endothelium in the human term placenta. Placenta, 22, 32-43.
6. Gervasi MT, Chaiworapongsa Y, Pacora P, Naccasha N, Yoon BH, Maymon E & Romero R (2001) Phenotypic and metabolic characteristics of monocyctes and granulocytes in preeclampsia. Am J Obstet Gynecol, 185, 792-797.
7. Haller H, Ziegler E-M, Homuth V, Drab M, Eichhorn J, Nagy Z, Busjahn A, Vetter K & Luft FC (1997) Endothelial adhesion molecules and leukocyte integrins in preeclamptic patients. Hypertension, 29, 291-296.
8. Halligan A, Bonnar J, Sheppard B, Darling M & Walshe J (1994) Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol, 101, 488-492.
9. Jaffe EA, Nachman RL, Becker CG & Minick CR (1993) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest, 52, 2745-2756.
10. Knight M, Redman CWG, Linton EA & Sargent IL (1998) Shedding of syncytiotrophoblast microvilli into the maternal circulation in preeclamptic pregnancies. Br J Obstet Gynaecol, 105, 632-640.
11. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA & Socol ML (1994) Tumor necrosis factor-a is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol, 170, 1752-1759.
12. Lyall F, Greer IA, Boswell F, Macara LM, Walker JJ & Kingdom JCP (1994) The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leucocyte activation? Br J Obstet Gynaecol, 101, 485-487.
13. Lyall F & Greer IA (1994) Pre-eclampsia: a multifaceted vascular disorder of pregnancy. J Hypertens, 12, 1339-1345.
14. Redman CWG & Sargent IL (2001) The pathogenesis of pre-eclampsia. Gynecol Obstet Fertil, 7-8, 518-522.
15. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EA, Martin JN Jr & Bennett WA (1999) Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynetol, 181, 915-920.
16. Schreiber E, Matthias P, Muller MM & Schaffner W (1989) Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res, 17, 6419.
17. Taylor RN, Crombleholme WR, Friedman SA, Jones LA, Casal DC & Roberts JM (1991) High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. Am J Obstet Gynecol, 165, 895-901.
18. Walsh SW & Wang Y (1995) Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J Clin Endocrinol Metab, 80, 1888-1893.
19. Wang Y & Walsh SW (1996) TNFα concentrations and MRNA expression are increased in preeclamptic placentas. J Reprod Immunol, 32, 157-169.
20. Wang Y, Adair CD, Coe L, Weeks JW, Lewis DF & Alexander JS (1998) Activation of endothelial cells in preeclampsia: Increased neutrophil-endothelial adhesion correlates with up-regulation of adhesion molecule P-selectin in human umbilical vein endothelial cells isolated from preeclampsia. J Soc Gynetol Invest, 5, 237-243.
21. Wang Y, Adair CD, Weeks JW, Lewis DF & Alexander JS (1999) Increased neutrophil-endothelial adhesion induced by placental factors is mediated by platelet-activating factor in preeclampsia. J Soc Gynecol Invest, 6, 136-141.
22. Wang Y & Walsh SW (2001a) Increased superoxide generation is associated with decreased superoxide dismutase activity and MRNA expression in placental trophoblast cells in preeclampsia. Placenta, 22, 206-212.
23. Wang Y, Gu Y, Philibert L & Lucas MJ (2001b) Neutrophil activation induced by placental factors in normal and pre-eclamptic pregnancies in vitro. Placenta, 22, 560-565.
24. Wang Y, Gu Y & Lucas MJ (2002) Expression of thrombin receptors in endothelial cells and neutrophils from normal and preeclamptic pregnancies. J Clin Endocrinol Metab, 87, 3728-3734.